Kim Sablich

Companies

• Jazz PharmaceuticalsEVP & GM, North America Jun 3, 2020 to Jun 7, 2023¹
• Eiger BioPharmaceuticals, Inc.Board member Apr 23, 2021 to Mar 3, 2023²
• Myovant Sciences Ltd.Chief Commercial Officer Dec 3, 2018 to Apr 7, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• JPJazz Pharmaceuticals JAZZ28,478 shares⁴$6.1M at $214.42Jun 5, 2023
• EBEiger BioPharmaceuticals, Inc.6,000 shares⁵Mar 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 5, 2023Returned to company 2,082 shares at $129.73 of Jazz Pharmaceuticals⁴
• Mar 8, 2023Sold 1,261 shares at $140.19 of Jazz Pharmaceuticals⁶
• Mar 8, 2023Sold 1,752 shares at $139.42 of Jazz Pharmaceuticals⁶
• Mar 5, 2023Shares withheld for tax 1,610 shares at $142.78 of Jazz Pharmaceuticals⁷
• Mar 3, 2023Granted 10,429 shares of Jazz Pharmaceuticals⁷
• Jun 7, 2022Sold 101 shares at $152.60 of Jazz Pharmaceuticals⁸
• Jun 7, 2022Sold 1,317 shares at $151.87 of Jazz Pharmaceuticals⁸
• Jun 7, 2022Sold 573 shares at $150.68 of Jazz Pharmaceuticals⁸
• Jun 7, 2022Sold 250 shares at $149.22 of Jazz Pharmaceuticals⁸
• Jun 7, 2022Sold 200 shares at $148.21 of Jazz Pharmaceuticals⁸
• Jun 6, 2022Sold 1,388 shares at $152.15 of Jazz Pharmaceuticals⁸
• Jun 6, 2022Shares withheld for tax 1,759 shares at $149.25 of Jazz Pharmaceuticals⁸
• Mar 11, 2022Granted 6,000 shares of Eiger BioPharmaceuticals, Inc.⁵
• Mar 5, 2022Shares withheld for tax 746 shares at $153.96 of Jazz Pharmaceuticals⁹
• Mar 3, 2022Granted 9,953 shares of Jazz Pharmaceuticals⁹
• Nov 11, 2021Sold 2,748 shares at $135.01 of Jazz Pharmaceuticals¹⁰